WHO expert panel recommends use of Sanofi Pasteur's dengue vaccine in endemic countries
The World Health Organization's (WHO) strategic advisory group of experts had recommended the use of Sanofi Pasteur's Dengvaxia dengue vaccine in endemic countries.
The recommendations were based on the review of data from 25 clinical studies undertaken in 15 different endemic and non-endemic countries across the world. As of March this year, Dengvaxia was licensed in Mexico, the Philippines, Brazil and El Salvador to prevent dengue from all four serotypes in individuals 9-45 years of age living in endemic areas.Sanofi said regulatory review processes for the vaccine are continuing in other countries where dengue is a public-health priority.Both public and private vaccinations have already started in the Philippines and negotiations are underway in the other approval countries for launches later this year.
Click on this link for more information.